Mitchell Herold, MD
Dr. Mitchell Herold is a board-certified Dermatologist and fellowship-trained Mohs micrographic and reconstructive surgeon. Originally from northwest Ohio, his academic journey led him to the Sunshine State, where he pursued his undergraduate studies at the University of Florida. Graduating with honors on the Dean’s List, he earned a degree in Microbiology and Cell Science. Dr. Herold remained at the University of Florida College of Medicine for his doctoral studies, where he graduated with honors in research.
Following medical school, he completed his medical internship in Orlando and Dermatology Residency at the University of Arizona in Tucson. During his residency, Dr. Herold distinguished himself as the Chief Resident of the Malcom Randall Veteran Affairs Hospital. To further enhance his expertise, he pursued and completed a Fellowship in Mohs Micrographic Surgery and Dermatologic Oncology under the tutelage of Dr. David Kent here at Skin Care Physicians of Georgia.
Throughout his career, Dr. Herold has actively engaged in research, focusing on cutaneous oncology, reconstructive surgery, and dermatology. Dr. Herold is unwavering in his commitment to delivering personalized, high-quality, evidence-based care. His approach is characterized by a dedication to tailoring each treatment to the individual needs of his patients, ensuring a personalized and effective healthcare experience.
Education:
Bachelor of Science – University of Florida
Doctor of Medicine – University of Florida
Internship – University of Central Florida
Dermatology Residency – University of Arizona
Micrographic Surgery and Dermatologic
Oncology Fellowship –Skin Care Physicians of Georgia and Atrium Health the Medical Center
Certifications:
Fellow of the American Academy of Dermatology
American Board of Dermatology Certified Dermatologist
Fellowship trained Mohs Surgeon
Selected Research Publications and Presentations:
• Herold M, Kent D, Kent S. Repair of an Upper Lip Defect. Dermatol Surg. 2024 May 3.
• Mehta P, Herold M, Krase J. Focal pigmentation of an eroded erythematous inguinal plaque in an older man. JAAD Case Rep. 2022 Jul 5;27:20-22.
• Herold M. Eruptive Dermal Abscesses in an Immunocompromised Patient. Pacific
Dermatology Association Spring Training Meeting. Scottsdale, AZ. May 2022.
• Herold M, Goldberg G. Combination Therapy for the Treatment of Complex Vascular Lesions. Lasers Surg Med. 2021 Dec;53(10):1316-1324.
• Winter A, Herold M, Sami N, Weinstein D. Treatment of Cutaneous Lupus Erythematosus With 1064-nm Neodymium-Doped Yttrium Aluminum Garnet Laser Verses Topical Corticosteroid Alone. Dermatol Surg. 2021 Jun;47(6):863-864.
• Herold M, Good AJ, Nielson CB, Longo MI. Use of Topical and Systemic Retinoids in Solid Organ Transplant Recipients: Update and Review of the Current Literature. Dermatol Surg. 2019 Dec;45(12):1442-1449.
• Herold M, Nielson CB, Braswell D, Merkel K, Walker A, Auerbach J, Kapil J, Motaparthi K. Clinicopathologic comparison of Rowell syndrome, erythema multiforme, and subacute cutaneous lupus erythematosus. J Am Acad Dermatol. 2019 Dec;81(6):1435-1438.
• Herold M, Nielson C, Longo-Imedio MI. Isotretinoin and candida immunotherapy for recalcitrant warts in solid organ transplant recipients. Dermatol Ther. 2019 Mar;32(2):e12803.
• Herold M, Richmond NA, Montuno MA, Wesson SK, Motaparthi K. Rapamycin for refractory discoid lupus erythematosus. Dermatol Ther. 2018 Sep;31(5)e12631.
